ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Hawaii » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Hawaii

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DON MATSUURA MD

Cardiovascular Disease

11,558

$841K

653
614 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $69

PON-SANG CHAN M.D.

Cardiovascular Disease

10,658

$898K

402
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $69

HOWARD BARBAROSH M.D.

Cardiovascular Disease

9,897

$507K

681
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $69

ALBERT ING M.D.

Cardiovascular Disease

7,937

$523K

609
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $69

OSAMU FUKUYAMA M.D.

Cardiovascular Disease

6,348

$463K

633
609 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $69

WESLEY KAI M.D.

Cardiovascular Disease

5,648

$366K

489
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $69

DJON LIM MD

Cardiovascular Disease

5,571

$227K

498
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$41
Average prescription price

Avg: $69

BENJAMIN GAMBOA MD

Cardiovascular Disease

5,222

$193K

189
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 29%

$37
Average prescription price

Avg: $69

JOANA MAGNO MD

Cardiovascular Disease

5,090

$244K

407
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $69

MICHAEL YEE M.D.,

Cardiovascular Disease

5,009

$386K

369
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $69

ROY KAMADA MD INC

Cardiovascular Disease

4,816

$473K

348
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 29%

$98
Average prescription price

Avg: $69

STEVEN AZUMA M.D.

Cardiovascular Disease

4,792

$550K

541
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 29%

$115
Average prescription price

Avg: $69

WESLEY WAKAI M.D.

Cardiovascular Disease

4,735

$295K

331
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $69

HIRO MAKINO M.D.

Cardiovascular Disease

4,416

$218K

516
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $69

JOHN KRISTOFICH M.D.

Cardiovascular Disease

4,179

$322K

374
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $69

BERT WONG MD

Cardiovascular Disease

3,850

$241K

232
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $69

WILLIAM DANG MD

Cardiovascular Disease

3,846

$227K

390
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $69

JOHN FUNAI M.D.

Cardiovascular Disease

3,831

$186K

391
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $69

JAMES MUTO MD

Cardiovascular Disease

3,452

$178K

311
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $69

HINGSON CHUN M.D.

Cardiovascular Disease

3,355

$162K

366
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $69

PHILLIP MILNE M.D.

Cardiovascular Disease

3,326

$176K

292
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $69

JEN-CHENG CHEN M.D.

Cardiovascular Disease

3,273

$282K

351
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 29%

$86
Average prescription price

Avg: $69

MICHAEL CHAN M.D.

Cardiovascular Disease

3,272

$191K

335
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 29%

$58
Average prescription price

Avg: $69

GREGG YAMADA M.D.

Cardiovascular Disease

3,201

$263K

316
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $69

DEREK PANG M.D.

Cardiovascular Disease

2,723

$238K

198
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 29%

$87
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank